Myint Naychi Tun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Myint Naychi Tun has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Than Than Aye
Department of Gastroenterology, Yangon General Hospital University of Medicine 1 Yangon Myanmar
3 shared publications Thet Mar Win
Department of Gastroenterology, Thingangyun General Hospital University of Medicine 2 Yangon Myanmar
2 shared publicationsThiri Tin
Department of Gastroenterology, Thingangyun General Hospital University of Medicine 2 Yangon Myanmar
2 shared publicationsAung Kyaw Thu
Department of Gastroenterology No 2 Military Hospital Yangon Myanmar
1 shared publication- Aye Min Soe
Department of Gastroenterology No 2 Military Hospital Yangon Myanmar
1 shared publication Aye Mya Mya Kyaw
Department of Gastroenterology, Thingangyun General Hospital University of Medicine 2 Yangon Myanmar
1 shared publication
Latest Publications
- 14 November 2025
- Published by Wiley in Helicobacter
- Vol. 30 (6) , e70090
Management of Helicobacter pylori Infection: Myanmar Consensus Report
Myanmar has a significant rate of Helicobacter pylori ( H. pylori ) infection among Southeast Asian countries. The complications of H. pylori infections are common in Myanmar, ranging from peptic ulcer bleeding to gastric cancer. Myanmar has an intermediate risk of gastric cancer. In view of increasing drug resistance particularly to triple therapy, a standard management guideline is needed in Myanmar for the effective management of H. pylori infection. This is the first consensus guideline in Myanmar for local clinical practice. The consensus group consisted of 39 gastroenterologists and clinicians from Myanmar GI & Liver Society (MGLS), who had discussions in integrated meetings and developed consensus statements with the Delphi method and focused on the grades of recommendations, levels of evidence, and rationales for the management of H. pylori infection in daily practice in Myanmar. Due to the limited availability of high‐quality local evidence, these consensus recommendations were based upon the best available evidence from the world's literature and guidelines, with special attention given to evidence from Myanmar. This consensus followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). The consensus level was defined as ≥ 80% for agreement on each statement. Finally, the panel reached a consensus on 26 statements which focus on four areas: (1) whom to test, (2) how to test, (3) whom to treat, and (4) how to treat with post‐treatment confirmation of H. pylori status. This consensus will guide the proper diagnosis and treatment of H. pylori infection. In order to prevent antibiotic resistance, H. pylori infected individuals must have successful eradication. Future studies require third‐line regimens and the development of antibiotic sensitivity tests. This consensus will serve as a useful guide for clinicians in their day‐to‐day clinical work.
- 14 November 2025
- Published by Wiley in Helicobacter
- Vol. 30 (6) , e70090
Management of Helicobacter pylori Infection: Myanmar Consensus Report
Myanmar has a significant rate of Helicobacter pylori ( H. pylori ) infection among Southeast Asian countries. The complications of H. pylori infections are common in Myanmar, ranging from peptic ulcer bleeding to gastric cancer. Myanmar has an intermediate risk of gastric cancer. In view of increasing drug resistance particularly to triple therapy, a standard management guideline is needed in Myanmar for the effective management of H. pylori infection. This is the first consensus guideline in Myanmar for local clinical practice. The consensus group consisted of 39 gastroenterologists and clinicians from Myanmar GI & Liver Society (MGLS), who had discussions in integrated meetings and developed consensus statements with the Delphi method and focused on the grades of recommendations, levels of evidence, and rationales for the management of H. pylori infection in daily practice in Myanmar. Due to the limited availability of high‐quality local evidence, these consensus recommendations were based upon the best available evidence from the world's literature and guidelines, with special attention given to evidence from Myanmar. This consensus followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). The consensus level was defined as ≥ 80% for agreement on each statement. Finally, the panel reached a consensus on 26 statements which focus on four areas: (1) whom to test, (2) how to test, (3) whom to treat, and (4) how to treat with post‐treatment confirmation of H. pylori status. This consensus will guide the proper diagnosis and treatment of H. pylori infection. In order to prevent antibiotic resistance, H. pylori infected individuals must have successful eradication. Future studies require third‐line regimens and the development of antibiotic sensitivity tests. This consensus will serve as a useful guide for clinicians in their day‐to‐day clinical work.
- Open Access
Spectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia—A First Report from Myanmar
Background: Dyspepsia is associated with a variety of benign and malignant gastrointestinal diseases. The aim of the study was to evaluate the spectrum of upper gastrointestinal endoscopic findings in patients presenting with dyspepsia.Methods: This is a retrospective study on consecutive patients with dyspepsia undergoing upper gastrointestinal endoscopy at the gastroenterology department of Thingangyun General Hospital, University of Medicine 2, Yangon, from January 1, 2017, to December 31, 2019.Results: In this study, 1650 patients were recruited retrospectively. Forty‐nine patients were excluded due to incomplete data entry. There were 883 female (55%) out of 1601 patients. The mean age was 50.5 ± 15.82 years. The endoscopic findings were gastric/duodenal erosion (10.8%), erosive esophagitis (5.1%), duodenal ulcer (3.5%), gastric ulcer (4.4%), gastroesophageal varices (3.49%), esophageal cancer (0.8%), and gastric cancer (5.3%); in which early‐onset gastric cancer contributed for 17.6%. Miscellaneous diagnoses were 4.2%, and findings were normal at 62.5%. Significant endoscopy findings were diagnosed in patients over 45 years of age. Helicobacter pylori infection was found in 40.6% of the total study population, 52% of gastric cancers, 50% of gastric ulcers, 51.2% of duodenal ulcers, and 49.3% of gastric/duodenal erosions.Conclusion: Significant endoscopic findings in dyspeptic patients are frequent in our data. A considerable number of gastric cancer were diagnosed in patients under 45 years of age. H. pylori is prevalent in our dyspepsia population. The age threshold of 40–45 years for both males and females could be reasonable for the use of endoscopy in patients with dyspepsia in our population.
Open AccessSpectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia—A First Report from Myanmar
Background: Dyspepsia is associated with a variety of benign and malignant gastrointestinal diseases. The aim of the study was to evaluate the spectrum of upper gastrointestinal endoscopic findings in patients presenting with dyspepsia.Methods: This is a retrospective study on consecutive patients with dyspepsia undergoing upper gastrointestinal endoscopy at the gastroenterology department of Thingangyun General Hospital, University of Medicine 2, Yangon, from January 1, 2017, to December 31, 2019.Results: In this study, 1650 patients were recruited retrospectively. Forty‐nine patients were excluded due to incomplete data entry. There were 883 female (55%) out of 1601 patients. The mean age was 50.5 ± 15.82 years. The endoscopic findings were gastric/duodenal erosion (10.8%), erosive esophagitis (5.1%), duodenal ulcer (3.5%), gastric ulcer (4.4%), gastroesophageal varices (3.49%), esophageal cancer (0.8%), and gastric cancer (5.3%); in which early‐onset gastric cancer contributed for 17.6%. Miscellaneous diagnoses were 4.2%, and findings were normal at 62.5%. Significant endoscopy findings were diagnosed in patients over 45 years of age. Helicobacter pylori infection was found in 40.6% of the total study population, 52% of gastric cancers, 50% of gastric ulcers, 51.2% of duodenal ulcers, and 49.3% of gastric/duodenal erosions.Conclusion: Significant endoscopic findings in dyspeptic patients are frequent in our data. A considerable number of gastric cancer were diagnosed in patients under 45 years of age. H. pylori is prevalent in our dyspepsia population. The age threshold of 40–45 years for both males and females could be reasonable for the use of endoscopy in patients with dyspepsia in our population.
- Open Access
- 6 July 2021
- Published by Hindawi Limited in GastroHep
- Vol. 3 (6) , 344-351
The status of Helicobacter pylori infection related extraintestinal diseases in Myanmar
Myanmar is one of the high prevalence of Helicobacter pylori (H. pylori) infection among South East Asia region. The incidence of gastric cancer was also comparable to global data. Myanmar has intermediate gastric cancer risk because the predominant H. pylori strains are Western type CagA and BabA. Many studies have demonstrated association of H. pylori infection with extra intestinal diseases as in pathogenic role. There are number of studies that have been done in regards to H. pylori infection and extra intestinal diseases in Myanmar. Autoimmune thrombocytopenia, Coronary artery disease, Parkinson’s diseases and dermatological diseases such as chronic urticaria, pemphigus and psoriasis were demonstrated positive association with H .pylori infection. Available studies, both full texts and abstracts which appeared in Union catalogue of Myanmar Health science link, were reviewed in this article. This is the first paper in Myanmar reviewing the prevalence of extra intestinal manifestation of H. pylori infection in Myanmar. Though the studies are mostly descriptive design and heterogeneous results, there are trend towards positive association of H. pylori infection and extra intestinal diseases in Myanmar.
- 6 July 2021
- Published by Hindawi Limited in GastroHep
- Vol. 3 (6) , 344-351
Open AccessThe status of Helicobacter pylori infection related extraintestinal diseases in Myanmar
Myanmar is one of the high prevalence of Helicobacter pylori (H. pylori) infection among South East Asia region. The incidence of gastric cancer was also comparable to global data. Myanmar has intermediate gastric cancer risk because the predominant H. pylori strains are Western type CagA and BabA. Many studies have demonstrated association of H. pylori infection with extra intestinal diseases as in pathogenic role. There are number of studies that have been done in regards to H. pylori infection and extra intestinal diseases in Myanmar. Autoimmune thrombocytopenia, Coronary artery disease, Parkinson’s diseases and dermatological diseases such as chronic urticaria, pemphigus and psoriasis were demonstrated positive association with H .pylori infection. Available studies, both full texts and abstracts which appeared in Union catalogue of Myanmar Health science link, were reviewed in this article. This is the first paper in Myanmar reviewing the prevalence of extra intestinal manifestation of H. pylori infection in Myanmar. Though the studies are mostly descriptive design and heterogeneous results, there are trend towards positive association of H. pylori infection and extra intestinal diseases in Myanmar.